triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial ⭐️topline results from TRIUMPH-1, 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Original Article: Triple–Hormone-Receptor Agonist Retatrutide

PoljakACrawfordJDSmytheGABrodatyHSlavinMJKochanNAet al

Data-dependent mass spectrometric acquisition was performed using a Bruker Maxis 4G UltraHigh Resolution Quadrupole Time of Flight instrument (Bruker Daltonics)

Analytical testing typically includes high-performance liquid chromatography (HPLC) to confirm purity levels and mass spectrometry (MS) to verify molecular weight and structural identity

Patient reports from real-world use, including online forums and reviews, occasionally mention back pain

You may need to be 18 or older and have tried a different medication first, like metformin, an oral diabetes medication